期刊文献+

重组人脑利钠肽联合硝酸甘油治疗心力衰竭疗效观察 被引量:4

Efficacy of RecoNbinant HuNan Brain Natriurctic Pcptide and Nitroglycerin for treatNent of heart failure
下载PDF
导出
摘要 目的观察重组人脑利钠肽联合硝酸甘油治疗心力衰竭的临床疗效。方法50例心力衰竭患者,随机分成对照组和治疗组各25例。对照组使用硝酸甘油注射液常规治疗,治疗组在常规治疗的基础上加用重组人脑利钠肽。结果重组人脑利钠肽联合硝酸甘油治疗后,rhBNP治疗组总有效率及24h后症状缓解率均优于对照组(P〈0.05),并且在临床疗效、呼吸、心率和血压也优于对照组(P〈0.05)。结论重组人脑利钠肽联合硝酸甘油治疗心力衰竭比单用硝酸甘油效果更优。 Objective To study the efficacy of RecoNbinant HuNan Brain Natriuretic Peptide and Nitroglycerin in treat Nent of patients with heart failure. Methods Fifty patients with heart failure were randomly divided into two groups, Patients in control group (n=25) were trearted with nitroglycerin, Patients in trial group (n=25) were treated with nitroglycerin added by RecoNbinant HuNan Brain Natri- uretic Peptide.Results After the treatment , the total effective rate and the symptom relief rate in the experimental group were all significantly better than that in the control group (P〈 0.05). And comparing with the control group, the clinic effects, including respiratory, heart rate and blood pressure were im- proved in the experimental group(P〈 0.05).Conclusion There were better clinic effects on treatment of heart failure by rhBNP combines with sodium nitroprusside than by single sodium nitroprusside.
出处 《国际医药卫生导报》 2011年第20期2466-2469,共4页 International Medicine and Health Guidance News
基金 深圳市科技计划项目(200903259)
关键词 重组人脑利钠肽 心力衰竭 效果 RecoNbinant HuNan Brain Natriuretic Peptide Heart failure Efficacy
  • 相关文献

参考文献7

  • 1Kapoor JR, Perazella NA. Diagnostic and therapeutic approach to acute decoNpensated heart failure [J]. AN J Ned, 2007, 120(2): 121-127.
  • 2Vicky AC, Leigh J. N inireview, Natriuretic peptides during develop Nent of the fetal heart and circulation [J]. Endocrinology, 2003, 144 (6): 2191-2194.
  • 3Roberto L, Serge N, Inder A, et al.Efects of Valsartan on circulating brain natriuretic peptide an norepingphrine in syNptoNatic chronic heart failure [J]. Circulation, 2002, 106(19): 2454-2458.
  • 4NiriaN TR, Richard AN. Cardiac natriuretic peptides for cardiac health [J]. Clinical Science, 2005, 108(12): 23-36.
  • 5FeilR, LonhN ann SN, de Jonge H, et al.Cyclic GNP- dependent protein kinases and the cardiovascular systeN: insights froN genetically Nodified Nice [J]. Circ Res, 2003, 93(10): 907-916.
  • 6Burger A.I. A review of the renal and neurohoNonal ef- fects of B-type natriuretic peptide [J]. Congest Heart Fail, 2005, 11(1): 30-38.
  • 7Kapoun AN, Liang F, O'Young G, et al.B- type natri- uretic peptide exerts broad functional opposition to transforNing growth factorbeta in priNary huNan cardiac fibroblasta fibrosis Nyofibroblast conversion prolifera- tion and inflaNNation [J]. Circ Res, 2004,94(1): 453- 461.

同被引文献35

  • 1赖长春,高伟栋,李浙成,应显星,胡智星,童跃锋.慢性心力衰竭时脑钠肽和C反应蛋白水平及卡维地洛的疗效[J].岭南心血管病杂志,2007,13(5):340-343. 被引量:21
  • 2张石,杨小霂.硝酸甘油复合艾司洛尔用于手术控制性降压的观察[J].中国基层医药,2007,14(7):1195-1196. 被引量:7
  • 3Suzuki S, Nonaka A, Abe F.Effect of esmolol on cardiovascular responses induced by scopolamine butylbromide[J].Masui, 2005, 54(11): 1277-1281.
  • 4Arbier G, Shettigar U, Appunn D.Clinical application of super short acting 13 -receptor blocker esmolol[J].Int J ClinPharmacolTher, 1995, 33: 212-218.
  • 5中华医学会心血管病分会.中华心血管病杂志编辑委员会.慢性心力衰竭诊断及治疗指南[J].中华心血管病杂志,2007,35(12):112-113.
  • 6Yin WH,Chen JW,Jen Hl,,et al. Independent prognostic val- ue of elevated high-sensitivity C-reactive protein in chronic'. heart failure [J]. Am Heart J,2004,147(5) :931-938.
  • 7Verma S, Kuliszewski MA, Li SH ,et al. C-reactive protein at- tenuates endothelial progenitor cell survival,differentiation,and function:further evidence of a mechanistic link between C-reactive protein and cardiovascular disease [J]. Circulation, 2004,109 : 2058-2067.
  • 8Ramani G,Zahid M,Good CB,et al. Comparison off requency of new-onset at rial fibrillation or flutter in patients on statins versus noton statins presenting with suspected acute coronary syndrome [J]. Am J Cardiol, 2007,100 (3) : 404-405.
  • 9Mueller C,Scloler A,Loule-Kilian K,et al. Use of B- type natriuretic peptide in the evaluation and management of acute dvsonea [J1. N Enl J Med,2004.350:647-654.
  • 10Gardner RS,Ozalp F, Murday AJ,et al. N-terminal pro-brain natriuretic peptide:a new gold standard in predicting mortality in patients with advanced heart failure [J]. Eur Heart J,2003,24: 1735-1743.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部